The global CAR T-cell therapy market was valued at US$ 4.7 Bn in 2025 and is projected to reach US$ 42.8 Bn by 2036, expanding at a CAGR of 22.3% from 2026 to 2036. Market growth is primarily driven by advancements in genetic engineering and technology and rising demand for personalized medicine. The increasing global cancer burden, growing adoption of individualized treatment approaches, and...